Showing results (51-60 of 105) with videos related to
Sort By:
Pageof 11
American Journal of Respiratory and Critical Care Medicine|October 6, 1999
Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus diseaseJ H Aberle, S W Aberle, M N Dworzak, et al.Journal of Virology|September 26, 2014
Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccinationJohanna Jarmer, Jürgen Zlatkovic, Georgios Tsouchnikas, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024David N Springer, Christian Borsodi, Jeremy V Camp, et al.European Journal of Pediatrics|June 26, 2015
Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, AustriaHerbert Kurz, Ruth Prammer, Wolfgang Bock, et al.Journal of Virology|May 3, 2014
Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope predictionJulia Schwaiger, Judith H Aberle, Karin Stiasny, et al.Open Forum Infectious Diseases|July 25, 2022
The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021Marianne Graninger, Stefan Hubmer, Franz Riederer, et al.The Journal of Infectious Diseases|November 12, 2010
Dynamic coinfection with multiple viral subtypes in acute hepatitis CJennifer A Smith, Judith H Aberle, Vicki M Fleming, et al.The Journal of Infectious Diseases|April 3, 2007
CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearanceJudith H Aberle, Gabriela Perstinger, Lukas Weseslindtner, et al.NPJ Vaccines|August 4, 2023
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variantsDavid N Springer, Michael Bauer, Iris Medits, et al.Cancers|April 23, 2022
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd VaccinationLorenz Schubert, Maximilian Koblischke, Lisa Schneider, et al.Pageof 11